Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6450
-0.0100 (-1.53%)
Feb 26, 2026, 3:18 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 226.29 million as of February 25, 2026. Its market cap has increased by 17.16% in one year.
Market Cap
226.29M
Enterprise Value
211.71M
Revenue
79.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 226.29M, a decrease of -44.14%. That is a compound annual growth rate of -9.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 226.29M | -11.37% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anteris Technologies Global | 836.20M |
| PolyNovo | 649.39M |
| Lumos Diagnostics Holdings | 206.24M |
| EMVision Medical Devices | 164.97M |
| SomnoMed | 144.17M |
| Cleo Diagnostics | 82.12M |
| Compumedics | 66.42M |
| Micro-X | 50.83M |